Hemangiol Uniunea Europeană - română - EMA (European Medicines Agency)

hemangiol

pierre fabre medicament - propranolol - hemangiom - agenți beta blocanți - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.

HEMANGIOL 3,75 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

hemangiol 3,75 mg/ml

farmea - franta - propranololum - sol. orala - 3,75 mg/ml - agenti betablocanti betablocante neselective